LDH and the MELD-LDH in Severe Acute Liver Injury and Acute Liver Failure: Preliminary Confirmation of a Novel Prognostic Score for Risk Stratification
The Journal of Applied Laboratory Medicine · 04.05.2023 · 8 (3) · 504-513
DOI: 10.1093/jalm/jfac137 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 10.02.2023. Verfasst von Jake R Price und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States. Hauptthemen laut MEDLINE: End Stage Liver Disease, Liver Failure, Acute. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
Acute liver failure (ALF) is a devastating condition with high mortality. Currently, liver transplantation is the only life-saving treatment, but the decision to transplant is difficult due to the rapid progression of ALF and persistent shortage of donor organs. Biomarkers that predict death better than current prognostics could help. To our surprise, proteomics recently revealed that lactate dehydrogenase (LDH) is prognostic in ALF by itself and in a novel form of the model for end-stage liver disease (MELD) score called the MELD-LDH. The purpose of this study was to confirm our proteomics results in a larger population.
Methods
We reviewed laboratory data from 238 patients admitted to the University of Arkansas for Medical Sciences Medical Center with a diagnosis of ALF and biochemical evidence of acute liver failure over a 12-year period, as well as subset of 170 patients with encephalopathy.
Results
LDH was strikingly elevated in the nonsurvivors at the time of peak injury. Receiver operating characteristic (ROC) curve analyses revealed that LDH by itself could discriminate between survivors and nonsurvivors on the first day of hospitalization, although not as well as the MELD and MELD-LDH scores that performed alike. Importantly, however, LDH by itself performed similarly to the MELD at the time of peak injury and the MELD-LDH score moderately outperformed both. The MELD-LDH score also had greater sensitivity and negative predictive value than the MELD and the King’s College Criteria.
Conclusions
The results support our prior finding that LDH and the MELD-LDH score predict death and therefore transplant need in ALF patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
- Department of Pathology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
- Department of Emergency Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
- Department of Environmental Health Sciences, College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR.
ORCID-Profile: Mitchell R McGill
Zitieren
APA
Price, J. R., Hagrass, H., Filip, A. B., & McGill, M. R. (2023). LDH and the MELD-LDH in Severe Acute Liver Injury and Acute Liver Failure: Preliminary Confirmation of a Novel Prognostic Score for Risk Stratification. The Journal of Applied Laboratory Medicine, 8(3), 504-513. https://doi.org/10.1093/jalm/jfac137
Vancouver
Price JR, Hagrass H, Filip AB, McGill MR. LDH and the MELD-LDH in Severe Acute Liver Injury and Acute Liver Failure: Preliminary Confirmation of a Novel Prognostic Score for Risk Stratification. The Journal of Applied Laboratory Medicine. 2023;8(3):504-513. doi:10.1093/jalm/jfac137
BibTeX
@article{Price2023,
author = {Price, Jake R and Hagrass, Hoda and Filip, Ari B and McGill, Mitchell R},
title = {LDH and the MELD-LDH in Severe Acute Liver Injury and Acute Liver Failure: Preliminary Confirmation of a Novel Prognostic Score for Risk Stratification},
journal = {The Journal of Applied Laboratory Medicine},
year = {2023},
volume = {8},
number = {3},
pages = {504--513},
doi = {10.1093/jalm/jfac137}
}
EUVIMED